These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36317858)

  • 1. Topical Metronidazole Versus Ivermectin for Low-density Demodex Rosacea: A Rater-blinded, Randomized, Split-face Trial.
    Yeh MC; Tsai J; Huang YC; Wang HH
    Acta Derm Venereol; 2022 Nov; 102():adv00811. PubMed ID: 36317858
    [No Abstract]   [Full Text] [Related]  

  • 2. Real-life experience on effectiveness and tolerability of topical ivermectin in papulopustular rosacea and antiparasitic effect on Demodex mites.
    Trave I; Merlo G; Cozzani E; Parodi A
    Dermatol Ther; 2019 Nov; 32(6):e13093. PubMed ID: 31579993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of rosacea with topical ivermectin.
    Ali ST; Alinia H; Feldman SR
    Drugs Today (Barc); 2015 Apr; 51(4):243-50. PubMed ID: 26020066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical ivermectin-induced transient flare of rosacea as a host reaction to killed Demodex mites preventable by short-term use of topical corticosteroid.
    Huang HP; Hsu CK; Lee JY
    Dermatol Ther; 2022 Jul; 35(7):e15517. PubMed ID: 35426191
    [No Abstract]   [Full Text] [Related]  

  • 5. Rosacea with persistent facial erythema and high Demodex density effectively treated with topical ivermectin alone or combined with oral carvedilol.
    Huang HP; Hsu CK; Lee JY
    Dermatol Ther; 2021 Mar; 34(2):e14899. PubMed ID: 33605018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual anti-inflammatory and anti-parasitic action of topical ivermectin 1% in papulopustular rosacea.
    Schaller M; Gonser L; Belge K; Braunsdorf C; Nordin R; Scheu A; Borelli C
    J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1907-1911. PubMed ID: 28653460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additional evidence that rosacea pathogenesis may involve demodex: new information from the topical efficacy of ivermectin and praziquantel.
    Abokwidir M; Fleischer AB
    Dermatol Online J; 2015 Sep; 21(9):. PubMed ID: 26437294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of reflectance confocal microscopy for the monitoring of rosacea during treatment with topical ivermectin.
    Logger JGM; Peppelman M; van Erp PEJ; de Jong EMGJ; Nguyen KP; Driessen RJB
    J Dermatolog Treat; 2022 Feb; 33(1):195-203. PubMed ID: 32189533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of in vitro Killing Effect of Thai Herbal Essential Oils, Tea Tree Oil, and Metronidazole 0.75% versus Ivermectin 1% on
    Paichitrojjana A; Chalermchai T
    Clin Cosmet Investig Dermatol; 2023; 16():1279-1286. PubMed ID: 37228784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Different Anti-Demodex Strategies: A Systematic Review and Meta-Analysis.
    Li J; Wei E; Reisinger A; French LE; Clanner-Engelshofen BM; Reinholz M
    Dermatology; 2023; 239(1):12-31. PubMed ID: 36310014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute inflammatory Demodex-induced pustulosis in an immunocompetent patient related to topical steroid use.
    Guzman AK; Gittler JK; Amin B; Srikantha R; Balagula Y
    Pediatr Dermatol; 2020 Sep; 37(5):985-986. PubMed ID: 32729151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demodex and rosacea revisited.
    Moran EM; Foley R; Powell FC
    Clin Dermatol; 2017; 35(2):195-200. PubMed ID: 28274359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superiority of ivermectin 1% cream over metronidazole 0·75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial.
    Taieb A; Ortonne JP; Ruzicka T; Roszkiewicz J; Berth-Jones J; Peirone MH; Jacovella J;
    Br J Dermatol; 2015 Apr; 172(4):1103-10. PubMed ID: 25228137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical Ivermectin Is Associated With Improved Erythematotelangiectatic, Papulopustular, and Phymatous Rosacea in a Secondary Analysis.
    Singh R; Perche PO; Kelly KA; Cook MK; Balogh EA; Richardson IM; Feldman SR
    J Drugs Dermatol; 2023 Oct; 22(10):1063-1064. PubMed ID: 37801528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ivermectin 1% cream for rosacea.
    Gupta G; Daigle D; Gupta AK; Gold LS
    Skin Therapy Lett; 2015; 20(4):9-11. PubMed ID: 26382711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical Ivermectin in the Treatment of Papulopustular Rosacea: A Systematic Review of Evidence and Clinical Guideline Recommendations.
    Ebbelaar CCF; Venema AW; Van Dijk MR
    Dermatol Ther (Heidelb); 2018 Sep; 8(3):379-387. PubMed ID: 29943217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical ivermectin-metronidazole gel therapy in the treatment of blepharitis caused by Demodex spp.: A randomized clinical trial.
    Ávila MY; Martínez-Pulgarín DF; Rizo Madrid C
    Cont Lens Anterior Eye; 2021 Jun; 44(3):101326. PubMed ID: 32461053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reflectance confocal microscopy for monitoring the density of Demodex mites in patients with rosacea before and after treatment.
    Sattler EC; Hoffmann VS; Ruzicka T; Braunmühl TV; Berking C
    Br J Dermatol; 2015 Jul; 173(1):69-75. PubMed ID: 25801631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe demodexfolliculorum-associated oculocutaneous rosacea in a girl successfully treated with ivermectin.
    Brown M; Hernández-Martín A; Clement A; Colmenero I; Torrelo A
    JAMA Dermatol; 2014 Jan; 150(1):61-3. PubMed ID: 24284904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demodicidosis or rosacea: what did we treat?
    Hoekzema R; Hulsebosch HJ; Bos JD
    Br J Dermatol; 1995 Aug; 133(2):294-9. PubMed ID: 7547401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.